WUSTL leads study of pediatric brain tumors

The National Cancer Institute (NCI) has awarded a five-year, $4 million grant to researchers at the School of Medicine to use genetically-engineered mice to study the origins and potential treatments of pediatric brain tumors. David H. Gutmann, the Donald O. Schnuck Family Professor of Neurology, is principal investigator of the grant, which is part of the NCI’s Mouse Models of Human Cancers Consortium. He is also on staff at Barnes-Jewish and St. Louis Children’s hospitals.

Tumors feel the deadly sting of nanobees

A computer simulation of a nanoparticle showing its core of perfluorocarbon (green) and its lipid coating (red, orange and blue).When bees sting, they pump poison into their victims. Now the toxin in bee venom has been harnessed to kill tumor cells by researchers at the School of Medicine. The researchers attached the major component of bee venom to nano-sized spheres that they call nanobees.

Food additive may one day help control blood lipids and reduce disease risk

Scientists at the School of Medicine have identified a substance in the liver that helps process fat and glucose. That substance is a component of the common food additive lecithin, and researchers speculate it may one day be possible to use lecithin products to control blood lipids and reduce risk for diabetes, hypertension or cardiovascular disease using treatments delivered in food rather than medication.
View More Stories